当前位置:
X-MOL 学术
›
Cancer Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Highlights from Recent Cancer Literature
Cancer Research ( IF 12.5 ) Pub Date : 2020-01-15 American Association for Cancer Research
Cancer Research ( IF 12.5 ) Pub Date : 2020-01-15 American Association for Cancer Research
![][1] Cells representing a BRCAness phenotype are vulnerable to PARP inhibitors and DNA damaging agents. However, most tumors do not demonstrate a BRCAness phenotype. Although recent studies reveal that BRCAness may be induced through inhibition of CDK12, small-molecule CDK12
中文翻译:
近期癌症文献集锦
![] [1]代表BRCAness表型的细胞易受PARP抑制剂和DNA破坏剂的侵害。然而,大多数肿瘤没有表现出BRCAness表型。尽管最近的研究表明BRCAness可能是通过抑制CDK12诱导的,但小分子CDK12
更新日期:2020-01-15
中文翻译:
近期癌症文献集锦
![] [1]代表BRCAness表型的细胞易受PARP抑制剂和DNA破坏剂的侵害。然而,大多数肿瘤没有表现出BRCAness表型。尽管最近的研究表明BRCAness可能是通过抑制CDK12诱导的,但小分子CDK12